Ferric carboxymaltose for anaemia in late pregnancy in Malawian women: a randomised controlled trial (Primary Analysis Dataset)
The dataset contains de-identified data of 589 pregnant women and their neonates from Southern Malawi, who were randomised in the REVAMP-TT (RandomisEd controlled trial of the Effect of intraVenous iron for Anaemia in Malawian Pregnant women in the Third Trimester) trial. This trial aimed to explore the effect of a single dose of a modern IV iron formulation (ferric carboxymaltose) compared to standard-of-care (oral iron) for anaemia treatment in Malawian pregnant women and their neonates up to 1-month post-partum.
This project contains six separate datasets and corresponding data dictionaries which underlie the variables used in the analysis of the main manuscript. These consist of:
- Baseline characteristics
- Maternal efficacy
- Neonate efficacy
- Maternal safety
- Neonate safety
- Maternal infusion related events
To maintain the privacy and confidentiality of the research participants, access is provided to de-identified data only. Certain variables have not been included due to their risk of re-identification, as outlined in the data dictionaries. These variables are available by the corresponding author (Sant-Rayn Pasricha: pasricha.s@wehi.edu.au) upon reasonable request. For reference, participant record identifiers for both the mothers and neonates were derived independently to reduce the risk of re-identification and therefore cannot be used to link the maternal and neonate data together.
